Successful Completion of $100m Tap Issue

Ittihad Successfully Completes $100 Million Tap Issue of Initial $350 Million Sukuk:

ABU DHABI, United Arab Emirates, July 15, 2024 (GLOBE NEWSWIRE) — Ittihad is pleased to announce the successful completion of a $100 million tap issue of its $350 million sukuk, originally issued in November 2023. The sukuk, which carries a coupon interest rate of 9.75%, will mature in November 2028.

The tap issuance was placed at an issue price of 102.1, resulting in a yield of 9.0%. This yield reflects an improvement over the original terms.

The proceeds from this new issue will be utilized to refinance existing debt, thereby extending the company's debt maturity profile and enhancing its financial flexibility.

The tap issue garnered strong interest from international investors, who accounted for 70% of the new issue (34.5% from the US Offshore accounts, 22% from the UK and 13.5% from Europe), with the remaining 30% from regional asset managers. This significant international participation underscores the growing confidence in Ittihad's strong financial profile and enhances the diversification of its investor base, serving the company's long–term strategic goals. The demand from investors is a testament to Ittihad's enduring success story and its ability to attract and retain the confidence of regional and international investors. The company remains committed to its strategic objectives and will continue to pursue initiatives that strengthen its financial position and drive sustainable growth.

J.P. Morgan acted as sole lead manager and bookrunner on this transaction.

For further information, please contact:

Wasfi Al Tayara
Corporate Finance and Investor Relations Manager
+971 2 6581888
investor.relations@ittihadinvestment.ae

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART IN OR INTO THE UNITED STATES OR TO, OR FOR THE ACCOUNT OR BENEFIT OF U.S. PERSONS (AS DEFINED IN REGULATION S UNDER THE U.S. SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”)) OR ANY OTHER JURISDICTION WHERE IT WOULD BE UNLAWFUL TO DO SO.

ENDS

About Ittihad
Ittihad is a privately owned business founded in 2008 and headquartered in the United Arab Emirates (UAE), with investments in the UAE, Saudi Arabia, and Egypt. The Company exports products and services to over 50 countries worldwide. It has a talented team of more than 8,000 members from over 57 nationalities with sector–wide expertise and a commitment to operational excellence.

Since 2015, Ittihad has pursued a strategy of investing in businesses with leading domestic positions in the UAE and the Gulf Cooperation Council (GCC), as well as strong international export potential. The Company focuses on long–term investments, all structured for business–to–business (B2B) export and designed to capture the unique value proposition offered by the UAE and the region.

Ittihad is committed to powering wealth creation through assets that balance profitability with sustainability and generate positive outcomes for stakeholders, society, and the planet.

This information is provided by Reach, the non–regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.


GLOBENEWSWIRE (Distribution ID 9177963)

Sabin Vaccine Institute Begins Phase 2 Clinical Trial for Sudan Ebolavirus Vaccine

Laboratory at Makerere University Walter Reed Project, where Sabin’s Phase 2 Sudan ebolavirus vaccine clinical trial begins this month.

WASHINGTON, July 15, 2024 (GLOBE NEWSWIRE) — Sabin Vaccine Institute launched a Phase 2 clinical trial for its vaccine against Sudan ebolavirus, with healthy volunteers receiving the single–dose vaccine at Makerere University Walter Reed Project (MUWRP) in Uganda. There are currently no approved vaccines for this strain of ebolavirus, which saw an outbreak end just last year. Ebolavirus disease kills on average half the people infected, according to the World Health Organization.

Sudan ebolavirus is a filovirus, in the same family as Marburg virus disease and Zaire ebolavirus, which killed 11,325 in one outbreak in West Africa from 2014–16. Ebolavirus disease spreads between people via direct contact with the blood or other bodily fluids of infected people and is highly virulent, causing hemorrhagic fever.

Based on the same cAd3 platform as its Marburg vaccine candidate, Sabin’s single–dose investigational Sudan ebolavirus vaccine was found to be promising in Phase 1 clinical and non–clinical studies, with results showing it to be safe, while eliciting rapid and robust immune responses that lasted up to 12 months.

This is Sabin’s second Phase 2 clinical trial partnership with MUWRP, based in Uganda’s capital, Kampala. A Phase 2 trial for a Marburg vaccine is already underway, having recently completed enrollment. Initial results from the Marburg trial are expected later this year.

Dr. Betty Mwesigwa, deputy executive director of MUWRP, is once again the principal investigator (PI) for the Sabin–sponsored trial for the Sudan ebolavirus vaccine. In the coming weeks, participants will also be enrolled at the Kenya Medical Research Institute in Siaya, Kenya, with Dr. Videlis Nduba serving as PI for that site. In all, 125 volunteers will participate in the trial across the two countries.

“We are delighted to advance a vaccine candidate that can thwart a deadly and devastating disease, especially one that caused a fairly recent outbreak and for which no approved treatments exist,” says Amy Finan, Sabin’s Chief Executive Officer. “Sabin’s vaccine candidate is backed by strong safety and immunogenicity data, and we hope this trial will yield further evidence to move the vaccine closer to licensure.”

The most recent outbreak of Sudan ebolavirus occurred in the fall of 2022 in Uganda, after six suspicious deaths in the Mubende district. That outbreak ultimately resulted in 55 deaths. Sabin’s vaccine was the first to arrive in Uganda during that outbreak after the World Health Organization included it as one of three vaccines for possible use in an outbreak trial. The outbreak ended on January 11, prior to vaccine being deployed for use.

“Makerere University Walter Reed Project is pleased to partner with the Sabin Vaccine Institute once again,” says Dr. Mwesigwa. “Uganda has the most experience with Sudan ebolavirus outbreaks so we understand the importance of testing and researching an effective Sudan ebolavirus vaccine that could be used in the event of an outbreak.”

The Phase 2 clinical trial will evaluate safety and immunogenicity for the vaccine among a larger group of individuals than in previous trials. This is a randomized, placebo–controlled, double–blind study, meaning that neither the participants nor the researchers will know whether trial participants receive a vaccine dose or a placebo dose until after the trial is over, an approach used to help reduce experimental bias.

Participants in the clinical trial will be monitored for a full year and will include both younger (18–50 years) and older age groups (51–70 years). Interim results are expected next year. In addition to the current trial in Uganda and Kenya, Sabin plans to conduct a similar Phase 2 clinical trial for Sudan ebolavirus vaccine in the U.S.

The Sudan ebolavirus vaccine trials are supported by the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services, under multi–year contracts between the organizations.

To date, Sabin has received around $216 million in contract awards from BARDA for furthering vaccine research and development against Sudan ebolavirus and Marburg virus diseases. BARDA and Sabin began working together in September 2019 to develop the two monovalent vaccine candidates.

This project has been supported in whole or in part with federal funds from the Department of Health and Human Services; Administration for Strategic Preparedness and Response; Biomedical Advanced Research and Development Authority (BARDA), under contract numbers 75A50119C00055 and 75A50123C00010.

About the Sabin Vaccine Institute

The Sabin Vaccine Institute is a leading advocate for expanding vaccine access and uptake globally, advancing vaccine research and development, and amplifying vaccine knowledge and innovation. Unlocking the potential of vaccines through partnership, Sabin has built a robust ecosystem of funders, innovators, implementers, practitioners, policy makers and public stakeholders to advance its vision of a future free from preventable diseases. As a non–profit with three decades of experience, Sabin is committed to finding solutions that last and extending the full benefits of vaccines to all people, regardless of who they are or where they live. At Sabin, we believe in the power of vaccines to change the world. For more information, visit www.sabin.org and follow us on X, @SabinVaccine.

About Sabin’s Vaccine R&D Using the cAd3 Platform

In August 2019, Sabin announced exclusive agreements with GSK for Sabin to advance the development of the prophylactic candidate vaccines against the deadly Zaire ebolavirus, Sudan ebolavirus and Marburg virus. The three candidate vaccines were initially developed collaboratively by the U.S. National Institutes of Health and Okairos, which was acquired by GSK in 2013. The candidate vaccines, based on GSK’s proprietary cAd3 platform, were further developed by GSK, including the Phase 2 development for the Zaire ebolavirus vaccine. Under the agreements between GSK and Sabin, Sabin exclusively licensed the technology for all three candidate vaccines and acquired certain patent rights specific to these vaccines.

About the Makerere University Walter Reed Project

MUWRP is a non–profit biomedical research organization with a mission to mitigate disease threats through quality research, health care and disease surveillance. The project’s scope includes, among others; clinical research in infectious and non–infectious diseases such as HIV, Ebola, Marburg, COVID–19, Influenza and Influenza–like illnesses, and neglected tropical diseases such as Schistosomiasis, among others. A major part of the clinical research are clinical trials, where the MUWRP has conducted more than 12 phase 1 and 2 vaccine clinical trials including the first Ebola vaccine trial in Africa.

Media Contact:
Monika Guttman
Media Relations Specialist
Sabin Vaccine Institute
+1 (202) 662–1841
press@sabin.org

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/7ea30f47–768e–4cd0–b0a3–19adff04b2ab


GLOBENEWSWIRE (Distribution ID 9177893)

LS Retail and FreedomPay partner to deliver unified payments worldwide

Philadelphia, Pennsylvania, July 15, 2024 (GLOBE NEWSWIRE) — LS Retail, an Aptos Company has partnered with FreedomPay, the world’s largest independent payment gateway. This partnership enables retail and hospitality businesses that use LS Retail software to deliver simpler, faster payment experiences to their customers with minimum effort. 

LS Retail: Supporting businesses around the world

Over 100,000+ retail, restaurant, pharmacy, forecourt, and hospitality businesses already rely on LS Retail software solutions to manage their entire operation. LS Central is LS Retail’s comprehensive retail management system that extends Microsoft Dynamics 365 Business Central ERP with industry–specific functionality. The solution enables businesses to run back–office operations, sales, financials, inventory, eCommerce, customer loyalty, and more on a single platform. LS Pay is an Electronic Fund Transfer (EFT) software solution that enables businesses using LS Central to have a choice when it comes to selecting a payment service provider (PSP) with out–of–the–box support for several PSPs in multiple regions.

FreedomPay: A leader of payment innovation

FreedomPay is a data–driven commerce platform delivering secure, seamless transactions across industries such as retail, food and beverage, and hospitality. The Next Level Commerce™ platform combines security, identity, payments, loyalty, and business intelligence into one solution, enabling businesses to offer a hyper–personalized purchasing experience for their customers while ensuring the highest level of safety and compliance across all channels.

Enhancing the payment experience together

Thanks to this new partnership, businesses running their operations on LS Retail software will be able to connect not only to FreedomPay, but also to any of the PSPs that leverage the white–labeled FreedomPay technology stack. The LS Pay–FreedomPay integration is available out–of–the–box to LS Central and LS Pay users. Included are advanced payment functionalities, including Point to Point Encryption (P2PE) capabilities and transaction analytics. Currently, the FreedomPay integration is available for PSPs in 75+ countries and continues to expand rapidly across the globe.

By taking advantage of the FreedomPay and LS Pay platforms, merchants can speed up and simplify the payment process across all channels, staying on the cutting edge of omnichannel payment technology without the need for a complex integration project.

“We are looking forward to a long–lasting partnership with FreedomPay,” says Petur Sigurdsson, Product Director of LS Pay at LS Retail. “Unified payments play a crucial role in delivering seamless experiences across all channels and our collaboration with FreedomPay underscores our commitment to providing businesses with the technology they need to stay ahead in a competitive landscape.”

“FreedomPay’s single unified platform brings industry–leading commerce innovation, security and global connectivity to merchants looking to take their businesses to the next level,” said Nate Ware, SVP Sales & Digital Development at FreedomPay. “Our partnership with LS Retail will enable merchants to offer best–in–class technology for a seamless commerce experience.” 

 

About LS Retail, an Aptos Company

LS Retail, an Aptos Company is a world–leading developer and provider of unified software solutions for retail, hospitality, food service, and pharmacy businesses.

The LS Retail solutions unite ERP, Point of Sale, e–commerce, order and inventory management, CRM, advanced analytics and more, in just one platform. Every day, over 100,000 stores, restaurants, pharmacies, resorts, and other businesses in 157 countries run on LS Retail software. Learn more at www.lsretail.com.

 

About FreedomPay

FreedomPay’s Next Level Commerce™ platform transforms existing payment systems and processes from legacy to leading edge and enables merchants to unleash the power of pay. As the premier choice for many of the largest companies across the globe in retail, hospitality, lodging, gaming, sports and entertainment, foodservice, education, healthcare and financial services, FreedomPay’s technology has been purposely built to deliver rock solid performance in the highly complex environment of global commerce.

The company maintains a world–class security environment and was one of the first payment solution providers in North America to be validated by the PCI Security Standards Council. FreedomPay’s robust solutions across payments, security, identity, and data analytics are available in–store, online and on–mobile and are supported by rapid API adoption. The award winning FreedomPay Commerce Platform operates on a single, unified technology stack across multiple continents allowing enterprises to deliver an innovative Next Level experience on a global scale. www.freedompay.com

 


GLOBENEWSWIRE (Distribution ID 9174115)

Minimum Deposit Casinos Announces Completion of Full Website Revamp

WATERFORD, Ireland, July 15, 2024 (GLOBE NEWSWIRE) — Minimum Deposit Casinos (MDC), a premier online resource for casino enthusiasts, is delighted to announce the successful completion of its comprehensive website redesign. Initiated in May, this ambitious project has seen the migration of all pages and regions to a sleek, modernized interface, enhancing the user experience across the board.

The revamped MDC website now features:

  1. Streamlined Navigation: Improved layout and intuitive menus facilitate easy access to game reviews, deposit guides, and casino recommendations, ensuring users can find the information they need quickly and efficiently.
  2. Enhanced Functionality: The new design boasts faster load times and a responsive interface, providing a seamless browsing experience on desktops, tablets, and smartphones.
  3. Updated Logo and Streamlined Featured Images: The website now sports a refreshed logo and streamlined featured images, contributing to a cohesive and visually appealing design.
  4. Modern Aesthetic: The site’s fresh look incorporates vibrant colours, engaging visuals, and a user–friendly interface, aligning with contemporary digital trends.

“We are thrilled to unveil the fully revamped Minimum Deposit Casinos website,” said Ian Dalgety, Senior SEO Analyst at MDC. “Starting in May, our team worked tirelessly to migrate all pages and regions to the new design. Our primary goal is to provide an unparalleled user experience, and we are confident that our users will appreciate the improved functionality and aesthetic of the new site.”

Discover the Best Deals on Low Deposit Casinos

As one of the top sites in the industry, MDC is committed to offering the best deals for low deposit casinos, from as low as $1 deposit options. Our comprehensive reviews and expert recommendations help users find the most advantageous offers and maximize their gaming experience without breaking the bank.

To explore the updated website and discover its new features, visit Minimum Deposit Casinos.

About Minimum Deposit Casinos

Minimum Deposit Casinos (MDC), a subdivision under OneTwenty Group, is dedicated to offering comprehensive reviews and information on the best minimum deposit casinos. Focusing on accessibility and user satisfaction, MDC helps casino enthusiasts find the perfect gaming experience that suits their budget and preferences.

Media Contact:

Sara Jacobs
SEO PR Strategist
Minimum Deposit Casinos
sara@onetwentygroup.com

Report Issues:

We strive to provide a flawless user experience. If you encounter any bugs or issues on our website, please report them to info@minimumdepositcasinos.org.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/507f1d90–528d–4128–9b40–21d753421a8a


GLOBENEWSWIRE (Distribution ID 1000971504)

How Vote Reflects Farmers’ View on India’s BJP’s Agrarian Policy Amid Climate Change

Farmers in Kashmir sow rice crops. Farmers voted against the ruling BJP because of its unpopular policies and lack of support, as uncertain weather conditions impact their livelihoods. Credit: Umer Asif/IPS

Farmers in Kashmir sow rice crops. Farmers voted against the ruling BJP because of its unpopular policies and lack of support, as uncertain weather conditions impact their livelihoods. Credit: Umer Asif/IPS

By Umar Manzoor Shah
SRINAGAR, Jul 15 2024 – On June 4, Ram Das, a 65-year-old farmer from India’s northern state of Haryana, was anxiously waiting for the results of the country’s general elections. It was early morning when he left his home and, along with his fellow villagers, congregated near a tea stall that had a transistor set playing the election results.

By 11 in the morning, Das had already sipped three cups of tea and smoked a few cigarettes. His anxiety was plummeting as the results hinted at a decreasing number of seats for India’s ruling Bharatiya Janata Party (BJP). He, along with the entire hamlet, had voted against the Narendra Modi government. “The farmers are not happy at all. We wanted to teach this government a lesson, and that is what we did,” Das told Inter Press Service. 

Despite securing a third term in government, the BJP’s overall election performance was described as a “shock” to Prime Minister Narendra Modi by several media sources. The party fell short of its goal of winning 400 out of 543 seats, managing to secure only 240 seats compared to 303 in the last elections that were held in the year 2019. Opposition parties saw significant success in states with large farming populations, such as Uttar Pradesh, Haryana, Maharashtra, Punjab, and West Bengal. Consequently, the BJP had to rely on the 28 cumulative seats from its allies to form the government.

An infographic of the number of seats won by India's ruling Bharatiya Janata Party (BJP) in the 2019 and 2024 elections for Rajasthan, Uttar Pradesh, Haryana, and Punjab have the largest farming populations. The blue bars represent the 2019 elections, and the red bars represent the 2024 elections. The numbers on top of the bars indicate the number of seats won by the BJP out of the total seats available in each state. Credit: Umar Manzoor Shah/IPS

An infographic of the number of seats won by India’s ruling Bharatiya Janata Party (BJP) in the 2019 and 2024 elections for Rajasthan, Uttar Pradesh, Haryana, and Punjab have the largest farming populations. The blue bars represent the 2019 elections, and the red bars represent the 2024 elections. The numbers on top of the bars indicate the number of seats won by the BJP out of the total seats available in each state. Credit: Umar Manzoor Shah/IPS

What went wrong and where?

When Narendra Modi first took office in 2014, he promised to reform the agriculture sector and double farmers’ incomes. However, government data from 2022 shows that farmers still live in squalid conditions, earning just Rs 28 ($0.34) per day.

Government data reveals that between 2018 and 2022, a staggering 53,478 farmers took their own lives, overwhelmed by mounting debt, inadequate compensation for their produce, and unpredictable weather conditions. This means 36 farmers were killing themselves every day during this period. “The numbers could be much higher than what is being projected in the government data. This could be the tip of an ice-berg. Many farmer suicides go unreported and never find place in government files,” says Abinav Sinha, a civil society activist based in Indian state of Uttar Pradesh.

In 2020, Modi’s government enacted three controversial agricultural laws without consulting farmers’ groups. This move sparked a massive year-long protest, as farmers feared the laws would lead to increased corporatization of agriculture and the elimination of state-backed protections, such as the minimum support price and the procurement of farm produce by state agencies.

The government ultimately repealed the controversial agricultural laws, but not before enforcing a severe crackdown on the protests. Authorities arrested farmers, barricaded highways to prevent them from reaching New Delhi, and deployed shotguns, pellets, and drones to disperse tear gas on unarmed protesters. As per the various farmers’ associations, over 570 farmers were killed during the protest.

In February of this year, farmers once again took to the streets, this time demanding legal guarantees for a minimum support price (MSP) for crops, among other issues. However, negotiations with government officials failed to yield any conclusive results.

This was the reason that the farmers associations across the country galvanized their efforts into political action and unanimously resolved to vote against the ruling Bharatiya Janata Party (BJP).

June 4: The D-Day

Farmers like Das from Haryana were one amongst the thousands of other farmers who didn’t allow the BJP candidates to even enter their villages for the campaigning. “They were ruthless for us when we sought the rollback of the draconian farm laws. How on earth should we vote for them? We will not even allow them to campaign here,” Das said.

On June 4, this year, election results were announced, and the country was shocked to find the states with a considerable amount of agrarian population voting against the BJP.

In Rajasthan, where the BJP had secured a victory in the state government last December, it won 14 out of 25 seats in the recent elections, a significant drop from winning all 25 seats in 2019.

In Uttar Pradesh, a state where 65 percent of the population relies on agriculture, the BJP managed to win just 33 out of 80 seats, a sharp decline from the 62 seats it secured in 2019 and 71 in 2014.

In Haryana, known as India’s breadbasket, the BJP’s count dropped to five seats out of the 10 available, compared to winning all 10 seats in 2019. The opposition Congress claimed the remaining five seats.

In Punjab, a leading producer of rice and wheat, the BJP failed to win any seats, drawing a blank in the state.

Government Cannot Ignore Climate Change Now

Pranav Shankar, a climate change activist based in New Delhi, told IPS that the general elections in India this year have shown a considerable trend that cannot be ignored, downplayed or undermined. “The farmers have spoken out.  This is the reality. To date, the government has ignored the importance of the farming community. From now on, the government has to remain assiduous towards the farmers’ needs and take measures to tackle climate change that is wreaking havoc in the country and putting the farmers in distress,” Shankar said.

He added that more than 33 electoral officers were killed due to heat stroke during the national elections in India this year. “No one talked about them. Even the government itself seems to have forgotten about those poor souls. This is all very unprecedented,” Shankar said.

Note: This feature is published with the support of Open Society Foundations.

IPS UN Bureau Report

 


!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?’http’:’https’;if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+’://platform.twitter.com/widgets.js’;fjs.parentNode.insertBefore(js,fjs);}}(document, ‘script’, ‘twitter-wjs’);  

The UK’s Chance for Change

Credit: Mike Kemp/In Pictures via Getty Images

By Andrew Firmin
LONDON, Jul 15 2024 – The political tide has turned in the UK – and civil society will be hoping for an end to government hostility.

The 4 July general election ended 14 years of rule by the right-wing Conservative party. The centre-left Labour party has returned to power, winning 411 out of 650 parliamentary seats.

Behind the headlines, however, there’s little reason to think the UK’s spell of political volatility is over, and the impacts of the deeply polarising 2016 Brexit referendum continue to ripple through politics.

Keir Starmer has become prime minister as a result of the UK’s most disproportionate election ever. The country’s archaic electoral system means his party won around 63 per cent of seats on just 34 per cent of the vote, up only around 1.5 per cent on its 2019 share and less than when it came second in 2017.

 

There was little perceptible public enthusiasm on display for Starmer and his promises of cautious reforms. But with high prices, failing public services and a housing crisis, many people wanted whatever change was available. Overwhelmingly the public mood was that the Conservative government was self-serving and out-of-touch and had to go.

Labour was far from the only beneficiary of haemorrhaging Conservative support. Smaller parties and independents took their biggest share of the vote in a century. The right-wing populist Reform UK party came third with 14.3 per cent of the vote, doing best in areas that had most strongly backed leaving the European Union, although the workings of the electoral system meant it won just five seats.

Labour’s resulting parliamentary majority is broad but shallow: it won many seats by small margins. Reform, having come second in 98 seats, can be expected to try to exploit the disarray in the Conservative Party, make as much noise as it can in parliament and hope for a breakthrough next time. Conservative politicians may well decide the lesson is to tack further right, and an alliance or merger between the two right-wing forces can’t be ruled out.

Discontent and disengagement were also indicated by a turnout of only 59.9 per cent, one of the lowest ever. There may be a several reasons: a sense Labour’s win was a foregone conclusion, and voter ID measures introduced by the last government that may have stopped 400,000 people voting. But it’s hard to escape the conclusion that at least some who stayed at home felt there was no point choosing between the parties on offer.

Time to reclaim rights

To address disaffection and stave off the threat of right-wing populism, Labour will need to show it can make a difference in addressing the UK’s economic and social malaise. One way it can signal a change and build positive partnerships to tackle problems is by respecting civic space and working with civil society. There’s plenty of room for improvement here.

Under the last government, hostility towards civil society grew and civic freedoms suffered. Last year, the UK’s civic space rating was downgraded to ‘obstructed’ by the CIVICUS Monitor, our collaborative research project that tracks the health of civic space around the world. The main reason was new laws that significantly increased restrictions on protests and expanded police powers to break them up and arrest protesters. Climate activists have been the main target.

As the outgoing government backtracked on its net-zero pledges and committed to more oil and gas extraction, campaigners increasingly embraced non-violent direct action. The government’s response was to vilify climate protesters, backed by laws that criminalise protests deemed to be noisy or disruptive. Mass arrests of protesters have become commonplace, and it’s no longer rare for people to receive jail sentences for protest-related offences. Recently, protesters against the monarchy and those demanding stronger action on Israel have faced similar treatment.

Meanwhile the outgoing government relentlessly fuelled public hostility towards migrants, particularly those crossing the English Channel in the absence of legal routes. Its ‘hostile environment’ policy led to the Windrush Scandal – in which people who’d lived legally in the UK for decades were detained and deported for want of documentation they’d never needed. More recently the government introduced its Rwanda policy, threatening to permanently remove people to the authoritarian East African state. When, in response to a civil society lawsuit, the European Court of Human Rights ruled the policy illegal because Rwanda wasn’t a safe country to send people to, the government passed a law declaring it safe, and its more right-wing politicians called for the UK to leave the court.

At the same time, the government raided its aid budget to cover the costs of hosting asylum seekers in the UK. The government merged its international development ministry into its foreign affairs ministry in 2020 and, in 2021, dropped its commitment to spend 0.7 per cent of gross national income on aid. Last year, it spent more than a quarter of its aid budget – money that should be used to help end poverty and inequality in the global south – on hosting asylum seekers in the UK.

As part of its rightward shift, the Conservative Party also backtracked on its commitments to LGBTQI+ rights, waging a culture war against trans rights, including by promising to ban gender-neutral bathrooms and prohibit discussion of gender identity in schools. The UK went from being Europe’s most LGBTQI+-friendly country to 16th. As happens every time politicians target an excluded group for vilification, hate crimes against trans people hit record levels.

This all leaves civil society with a big agenda to take to the new government. There’ve been some early encouraging signs. The government has dropped the Rwanda plan. It’s reversed an onshore wind farm ban. But there are many more advocacy asks. The best way to signal a new beginning would be to commit to respecting and repairing the space where demands can be articulated: rebuilding relationships with civil society, restoring the right to protest and reversing attacks on human rights.

Andrew Firmin is CIVICUS Editor-in-Chief, co-director and writer for CIVICUS Lens and co-author of the State of Civil Society Report.

 


!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?’http’:’https’;if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+’://platform.twitter.com/widgets.js’;fjs.parentNode.insertBefore(js,fjs);}}(document, ‘script’, ‘twitter-wjs’);  

From Trauma to Triumph: Kenyan Women’s Courageous Battle Against Female Genital Mutilation

Naomy Kolian and Jane Kaliko share light moments after a tiring day of engaging the community at a public forum on the need to stop FGM. Credit: Robert Kibet/IPS

Naomy Kolian and Jane Kaliko share light moments after a tiring day of engaging the community at a public forum on the need to stop FGM. Credit: Robert Kibet/IPS

By Robert Kibet
NAIROBI, Jul 15 2024 – In the heart of Empash village, a fragmented community nestled in Suswa, Narok County, some 62 miles northwest of Nairobi, Naomy Kolian’s story unfolds like a gripping saga of pain, resilience, and unyielding determination.

It was here, amidst the familiar surroundings of her home, that she was subjected to female genital mutilation (FGM), a brutal tradition that left her with physical and emotional scars. This hidden trauma would linger, haunting her well into adulthood.

Here, the Maasai culture thrives on a tapestry of rich traditions and deep-seated customs. The rhythmic chants of age-old songs blend with the distant bellowing of cattle, painting a picture of pastoral tranquility. Yet, beneath this picturesque veneer lies a harrowing reality for many Maasai women, which Naomy Kolian knows all too well.

A mother of five and a fierce advocate against FGM, a practice that nearly shattered her life, Naomy is a testament to the strength of the human spirit.

Her journey began with an unlikely opportunity. Compassion International, a Christian humanitarian organization, offered her the chance to attend school in a community where educating girls is often undervalued.

She thrived in both academics and athletics, becoming one of the best runners in her primary school. But this promising future was abruptly interrupted when, at the age of 14, after her final primary school examinations, she was forced to undergo FGM—a rite of passage that would rob her of her athletic potential and much more.

“We were taken to where my mother was,” Naomy recalls, her voice tinged with a mix of pain and resilience. “There, we found several people with a cow slaughtered. When I asked what was happening, I was lied to and told that nothing was going on. My mother finally disclosed that I was to undergo the cut since all my friends had already done so.”

The following morning, Naomy was placed under the custody of elderly women inside a manyatta, a traditional mud-walled house. The ordeal that followed was nothing short of a nightmare. In the cold, early hours, she was taken outside, stripped, and doused with ice-cold water meant to numb her nerves.

“That is when I fainted,” she says, wiping away tears with the palm of her hand.

Naomy’s voice wavers as she describes the excruciating details of her mutilation. She was sat down and held to the ground by strong women. Despite her struggles, she managed to overpower them temporarily, but this only led to more brutal measures.

“They chose to tie ropes on both legs and pass them through pierced holes in the wall. Men outside held the ropes, which forced my legs apart, giving the elderly woman ample time to carry out her assignment,” she explains, recounting how she felt one leg go numb.

In the Maasai community, FGM lacks a precise method, often resulting in severe complications. Naomy continued to bleed profusely, and the women attending to her resorted to applying sugar, honey, and cold milk to the wound. When these remedies failed, they tied her legs together in a futile attempt to stop the bleeding. Desperation led them to extract almost a liter of fresh cow’s blood, which they forced her to drink, hoping it would stem the blood loss.

Naomy’s ordeal is a stark representation of the plight faced by many Maasai women, who endure such inhumane practices under the guise of cultural preservation.

Lilian Saruni, also a victim, is a mother of seven, married to an elderly man with ten wives. “I engage in the beading business to enable me to educate my children so they can get a basic education,” she says.

“My husband issued curse threats that whoever would prevent the daughters from undergoing the cut would die, including the practitioner,” she shares. With support from the area chief and clergy, Lilian managed to protect her daughter and expand her efforts to help other girls.

Using her own experience as a powerful narrative, Naomy is today one of Kenya’s most powerful and persuasive advocates for the eradication of FGM. As the founder of a grassroots organization, Eselenge Engayion, she focuses on empowering the youth and providing safe havens for girls fleeing forced knife in her native village.

“The pain I went through is fresh in my mind to date, and the worst of it is that I lost my sporting talent completely,” she confides. Yet, her resolve remains unbroken.

“Teachers in high school would punish me for not participating in the sport indicated in my certificate, mistaking my inability to participate as ignorance,” Naomy says.

Determined not to let her past define her future, Naomy persisted. “I said to myself, I should not give up. I told my father that I would proceed to college. An old man was brought home. They resisted, saying that since I had undergone the cut, I should be married. That is when I decided to fake it and got into a relationship with a young man whom I did not love. That’s where I got pregnant,” she narrates.

The fear of hospitals due to the scars from FGM compounded her struggles during childbirth. “I feared going to the hospital because of the rupture due to the scar. I had a premature birth. I asked mom what was happening and she encouraged me, saying it is usually that way. I was referred to Kijabe Hospital. I could not walk properly,” she shares.

Her second birth was equally painful, but with the support of her understanding husband, Naomy managed to pursue a certificate course in Early Childhood Development Education (EDE). She worked as a volunteer, using every opportunity to educate young children and girls on the effects of FGM.

Prof. Patrick Muia Ndavi, an associate professor of obstetrics and gynecology at the University of Nairobi, explains, “When you look at the drivers of FGM, they say it is a cultural issue, a religious issue. But even when we ask which religion supports this practice, they can’t quantify which religion prescribes this vice.”

He continues to highlight the severe harm inflicted upon girls and women, stating, “FGM violates bodily integrity and has led to the deaths of some women and girls. In Kenya, FGM can cause fistula, which affects the communication between the bladder and the birth canal. Young mothers forced to undergo the cut often have children who develop cerebral palsy.”

Muia underscores the chronic, lifelong complications of FGM, which span medical and mental health issues. “Women and girls suffer from anxiety and fear of intimacy, especially where the worst forms of the practice are carried out,” he notes.

Jane Soipan Letooya, a poet from the Keekonyoike location, uses her talent to speak out against FGM. “FGM, taken as a cultural practice, makes it rampant in our community. The practice has cut off the future of many girls,” she asserts. Jane started her campaign in 2020, during the COVID-19 pandemic, motivated by the fear and loss experienced by her classmates.

Sharon Saruni, a 23-year-old student, was rescued by her mother, Lilian Saruni, from her father’s aggression.

“There is a need for a common discussion among stakeholders to dig into the root cause of this rampant vice among the Maasai community,” Sharon insists. She urges fellow girls to speak out without fear, highlighting the low self-esteem and shattered dreams caused by FGM.

According to the Somaliland Ministry of Social Affairs and a 2020 UNFPA report, Somaliland has the world’s highest recorded prevalence of FGM, with about 98 percent of women aged 15-49 having undergone FGM.

Article 8 of the Somaliland Constitution guarantees women the right to be free from violence. However, there is currently no viable anti-FGM policy approved. The Ministry of Social Affairs, in collaboration with relevant stakeholders, is drafting an anti-FGM policy that has been submitted to the cabinet for approval.

“This policy will support and back up the fight against FGM in Somaliland. Without the policy, there is no reference to take action against perpetrators. This policy will significantly enhance our interventions in ending FGM,” Yahye Mohamed, a TGG-ALM team lead, also working for Action Aid Somaliland, told IPS in a virtual interview.

The ongoing conflict in the east and the drought have disrupted the speed of the fight against FGM and the approval of the policy.

Jacinta Muteshi, the regional team leader of The Girl Generation-Support to the Africa-Led Movement dubbed TGG-ALM, noted that the prevalence rates remain very high in many Eastern African countries.

“We have been at the forefront in supporting those leading the fight against FGM in the East Africa region,” she told IPS in an interview.

TGG-ALM is a consortium led by Options Consultancy Services, which includes Amref Health Africa, Action Aid, the Orchid Project, the Africa Coordination Centre for the Abandonment of FGM/C, and the University of Portsmouth. The consortium is actively working in Kenya, Ethiopia, and Somaliland for the East Africa region and Senegal to combat FGM/C.

At a recent AU conference in Tanzania, government representatives highlighted the importance of collaborative actions, emphasizing the need to harmonize laws and penalties, establish hotlines for at-risk individuals, and standardize definitions of FGM to unify their approaches.

“If you look at the African continent, for the 28 countries where the prevalence is high, we are talking about 55 million girls experiencing FGM. Early and forced marriages are often aligned with these prevalence rates,” Muteshi told IPS.

In Kenya, there is a strong stance against FGM by the leadership in terms of policy, resources, and public statements. In Senegal, Amref Health Africa and Action Aid have engaged with parliamentarians to stress the significance of harmonizing regional laws for eradicating FGM/C.

“Many countries have laws, but their inconsistency in enforcing them or allocating resources to make those efforts effective is a concern. Hence, there is a need to bring parliamentarians together to highlight these issues,” Muteshi added.

The recent UNICEF report titled Female Genital Mutilation: A Global Concern-2024 says though the pace of progress is picking up, the rate of decline would need to be 27 times faster to meet the target of eliminating female genital mutilation by 2030, in line with the UN SDG on eliminating harmful practices by 2030.

Saruni Reson, a senior chief in Enosupukia, Narok East sub-county, has lived in Oloserian for five decades. A former teacher, he began fighting against FGM by setting an example with his daughters.

“As a family, we have saved 59 girls from undergoing the cut, and we are on a mission to spread the message against this vice,” he states.

Reson highlights the challenges faced in the fight against FGM. “Distance is one of the main challenges, especially when it comes to mobility coupled with the locality’s terrain when it rains,” he says. Despite these obstacles, the community’s security model, including village elders and local police, has been instrumental in rescuing girls.

“The government’s vision to eradicate the cut by 2030 will be achieved through our assistance, but we target to achieve this before that time,” he affirms. Reson calls for the establishment of safe homes near educational facilities, providing girls with a refuge and a chance for a better future.

IPS UN Bureau Report

 


!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?’http’:’https’;if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+’://platform.twitter.com/widgets.js’;fjs.parentNode.insertBefore(js,fjs);}}(document, ‘script’, ‘twitter-wjs’);  

 

Nyxoah Nomme Scott Holstine Chief Commercial Officer

Nyxoah Nomme Scott Holstine Chief Commercial Officer

Mont–Saint–Guibert, Belgique – 15 juillet 2024, 8h00 CET / 2h00 ET – Nyxoah SA (Euronext Brussels/ Nasdaq : NYXH) (“Nyxoah” ou la “Société”) opère dans le secteur des technologies médicales et se concentre sur le développement et la commercialisation de solutions innovantes destinées à traiter le Syndrome d’Apnées Obstructives du Sommeil (SAOS). La Société a annoncé la nomination de Scott Holstine au poste de Chief Commercial Officer. À ce titre, Scott dirigera les opérations commerciales de Nyxoah afin d'assurer le succès du lancement aux États–Unis.

Scott apporte plus de 26 ans d'expérience dans l'industrie des dispositifs médicaux, avec une expérience reconnue dans le lancement de produits aux États–Unis, la mise en place et la direction d'organisations commerciales caractérisées par une forte exécution opérationnelle. Scott est un fervent avocat du développement des personnes et des talents. Scott a été lauréat du Superintendent's Award for Excellence (Star Wreath) de la United States Military Academy de West Point, à New York. Après avoir servi comme capitaine dans la U.S. Army, Scott a obtenu son MBA à l'Université du Minnesota, Carlson School of Management – Minneapolis, MN.

“Alors que nous attendons l'approbation de la FDA d'ici la fin de l'année 2024, le recrutement d'un leader commercial expérimenté est déterminant pour accélérer davantage notre stratégie de mise sur le marché aux États–Unis dans un plan d'exécution de lancement concret. Cela commence par la mise en place d'une équipe commerciale pleinement opérationnelle d'ici la fin de l'année. Scott est un leader dynamique et créatif qui a su développer des équipes performantes et de nouveaux marchés pour des technologies innovantes”, a commenté Olivier Taelman, CEO de Nyxoah. “Cette nomination marque le coup d'envoi de la constitution d'une équipe de professionnels de classe mondiale, centrée sur les patients et les cliniciens, soutenant la mission de Nyxoah qui consiste à rendre le sommeil à nouveau simple pour les patients souffrant de SAOS.”

“C'est une période prometteuse pour les patients souffrant de SAOS. Les excellents résultats de l'étude DREAM de Nyxoah et le succès de Genio sur les marchés en dehors des États–Unis ont démontré le potentiel de la solution unique et révolutionnaire de Genio. Les patients et les médecins attendent avec impatience l'arrivée d'un deuxième acteur dans le domaine du HGNS. Je suis ravi de faire partie de l'équipe qui met en place une opération commerciale axée sur le patient et qui donne la priorité à la réussite de nos partenaires fournisseurs de soins de santé dans le traitement du SAOS”, a ajouté Scott.

A propos de Nyxoah

Nyxoah opère dans le secteur des technologies médicales. Elle se concentre sur le développement et la commercialisation de solutions innovantes destinées à traiter le Syndrome d’Apnées Obstructives du Sommeil (SAOS). La principale solution de Nyxoah est le système Genio®, une thérapie de neurostimulation du nerf hypoglosse sans sonde et sans batterie qui a reçu le marquage CE, centrée sur le patient et destinée à traiter le Syndrome d’Apnées Obstructives du Sommeil (SAOS), le trouble respiratoire du sommeil le plus courant au monde. Ce dernier est associé à un risque accru de mortalité et des comorbidités, dont les maladies cardiovasculaires. La vision de Nyxoah est que les patients souffrant de SAOS doivent pouvoir profiter de nuits réparatrices et vivre pleinement leur vie.

À la suite de la réussite de l'étude BLAST OSA, le système Genio® a reçu son marquage CE européen en 2019. Nyxoah a réalisé deux introductions en bourse réussies : sur Euronext Bruxelles en septembre 2020 et sur le NASDAQ en juillet 2021. Suite aux résultats positifs de l'étude BETTER SLEEP, Nyxoah a reçu l'approbation du marquage CE pour l'élargissement de ses indications thérapeutiques aux patients atteints de Collapse Concentrique Complet (CCC), actuellement contre–indiqués dans la thérapie des concurrents. En outre, la Société mène actuellement l'étude pivot DREAM IDE en vue d'obtenir l'approbation FDA et de commercialisation aux États–Unis.

Pour plus d'informations, veuillez consulter le rapport annuel de la société pour l'exercice 2023 et visiter le site suivant http://www.nyxoah.com/.

Attention – Marquage CE depuis 2019. Dispositif expérimental aux États–Unis. Limité par la loi fédérale américaine à un usage expérimental aux États–Unis.

Déclarations Prospectives

Certaines déclarations, croyances et opinions contenues dans le présent communiqué de presse sont de nature prospective et reflètent les attentes actuelles de la société ou, le cas échéant, des administrateurs ou de la direction de la société concernant la conclusion de l'accord de facilité de prêt et de l'accord de bons de souscription synthétiques avec la BEI, l'utilisation du produit de l'accord de facilité de prêt ; le système Genio® et les études cliniques en cours sur le système Genio® ; les avantages potentiels du système Genio® ; les objectifs de Nyxoah concernant le développement, la voie réglementaire et l'utilisation potentielle du système Genio® ; l'utilité des données cliniques pour l'obtention éventuelle de l'approbation de la FDA pour le système Genio® ; la communication des données de l'essai pivot DREAM U. U. de Nyxoah, le dépôt d'une demande d'approbation auprès de la FDA et l'entrée sur le marché américain. De par leur nature, les déclarations prospectives impliquent un certain nombre de risques, d'incertitudes, d'hypothèses et d'autres facteurs susceptibles d'entraîner une différence matérielle entre les résultats ou événements réels et ceux exprimés ou sous–entendus dans les déclarations prospectives. Ces risques, incertitudes, hypothèses et facteurs pourraient avoir une incidence négative sur les résultats et les effets financiers des plans et des événements décrits dans le présent document. En outre, ces risques et incertitudes comprennent, sans s'y limiter, les risques et incertitudes énoncés dans la section “Facteurs de risque” du rapport annuel de la société sur le formulaire 20–F pour l'exercice clos le 31 décembre 2023, déposé auprès de la Securities and Exchange Commission (“SEC”) le 20 mars 2024, et des rapports ultérieurs que la société dépose auprès de la SEC. Une multitude de facteurs, y compris, mais sans s'y limiter, les changements dans la demande, la concurrence et la technologie, peuvent faire en sorte que les événements, les performances ou les résultats réels diffèrent de manière significative de tout développement anticipé. Les déclarations prospectives contenues dans le présent communiqué de presse concernant des tendances ou des activités passées ne constituent pas des garanties de performances futures et ne doivent pas être considérées comme une déclaration selon laquelle ces tendances ou activités se poursuivront à l'avenir. En outre, même si les résultats ou développements réels sont conformes aux déclarations prospectives contenues dans le présent communiqué de presse, ces résultats ou développements peuvent ne pas être représentatifs des résultats ou développements des périodes futures. Aucune déclaration ou garantie n'est donnée quant à l'exactitude ou à la justesse de ces déclarations prévisionnelles. En conséquence, la Société décline expressément toute obligation ou tout engagement de publier des mises à jour ou des révisions des déclarations prospectives contenues dans le présent communiqué de presse à la suite d'un changement des attentes ou d'un changement des événements, conditions, hypothèses ou circonstances sur lesquels ces déclarations prospectives sont basées, sauf si la loi ou la réglementation l'exige expressément. Ni la Société, ni ses conseillers ou représentants, ni aucune de ses filiales, ni les dirigeants ou employés de ces personnes ne garantissent que les hypothèses sous–jacentes à ces déclarations prospectives sont exemptes d'erreurs et n'acceptent aucune responsabilité quant à l'exactitude future des déclarations prospectives contenues dans ce communiqué de presse ou quant à la survenance effective des développements prévus. Vous ne devriez pas accorder une confiance excessive aux déclarations prospectives, qui ne sont valables qu'à la date du présent communiqué de presse.

Contact :

Nyxoah
David DeMartino, Chief Strategy Officer
IR@nyxoah.com

Media
Belgique / France
Backstage Communication – Gunther De Backer
gunther@backstagecom.be

International/ Allemagne
MC Services – Anne Hennecke
anne.hennecke@mc–services.eu

Pièce jointe


GLOBENEWSWIRE (Distribution ID 1000971439)

Nyxoah Appoints Scott Holstine as Chief Commercial Officer

Nyxoah Appoints Scott Holstine as Chief Commercial Officer

Mont–Saint–Guibert, Belgium – July 15, 2024, 8:00am CET / 2:00am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced the appointment of Scott Holstine as Chief Commercial Officer. In this role, Scott will lead the commercial operations of Nyxoah enabling a successful U.S. launch.

Scott brings over 26 years of experience in the medical device industry with a proven track record in U.S. product launches, building and leading commercial organizations trademarked by strong operational execution. Scott is a passionate advocate for people and talent development. Scott graduated with the Superintendent’s Award for Excellence (Star Wreath) from the United States Military Academy at West Point, NY. After serving as a Captain in the U.S. Army, Scott received his MBA from the University of Minnesota, Carlson School of Management – Minneapolis, MN.

“As we expect FDA approval by the end of 2024, the hiring of an experienced commercial leader is instrumental in further accelerating our U.S. go–to–market strategy into a concrete launch execution plan. This starts with having a commercial team fully operational by year–end. Scott is a dynamic and creative leader with countless accomplishments in building high–performing teams and developing new markets for innovative technologies,” commented Olivier Taelman, Nyxoah Chief Executive Officer. “This appointment is the kickoff of building a team of world–class patient– and clinician–focused professionals, supporting Nyxoah’s mission to make sleep simple again for OSA patients.”

“This is a promising time for patients with OSA. Nyxoah’s strong DREAM study results and Genio’s success in markets outside of the U.S. have demonstrated the potential of Genio’s breakthrough and unique solution. Both patients and physicians are eagerly awaiting a second player in the HGNS field. I am thrilled to be part of the team building out a patient–focused commercial operation that prioritizes the success of our healthcare provider partners in treating OSA,” added Scott.

About Nyxoah
Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA). Nyxoah’s lead solution is the Genio® system, a patient–centered, leadless and battery–free hypoglossal neurostimulation therapy for OSA, the world’s most common sleep disordered breathing condition that is associated with increased mortality risk and cardiovascular comorbidities. Nyxoah is driven by the vision that OSA patients should enjoy restful nights and feel enabled to live their life to its fullest. 

Following the successful completion of the BLAST OSA study, the Genio® system received its European CE Mark in 2019. Nyxoah completed two successful IPOs: on Euronext Brussels in September 2020 and NASDAQ in July 2021. Following the positive outcomes of the BETTER SLEEP study, Nyxoah received CE mark approval for the expansion of its therapeutic indications to Complete Concentric Collapse (CCC) patients, currently contraindicated in competitors’ therapy. Additionally, the Company announced positive outcomes from the DREAM IDE pivotal study for FDA and U.S. commercialization approval.

For more information, please see the Company’s annual report for the financial year 2023 and visit http://www.nyxoah.com/.

Caution – CE marked since 2019. Investigational device in the United States. Limited by U.S. federal law to investigational use in the United States.

Forward–looking statements

Certain statements, beliefs and opinions in this press release are forward–looking, which reflect the Company’s or, as appropriate, the Company directors’ or managements’ current expectations regarding the entry into of the loan facility agreement and the synthetic warrant agreement with the EIB; the use of proceeds from the loan facility agreement; the Genio® system and ongoing clinical studies of the Genio® system; the potential advantages of the Genio® system; Nyxoah’s goals with respect to the development, regulatory pathway and potential use of the Genio® system; the utility of clinical data in potentially obtaining FDA approval of the Genio® system; reporting data from Nyxoah’s DREAM U.S. pivotal trial; filing for FDA approval; and entrance to the U.S. market. By their nature, forward–looking statements involve a number of risks, uncertainties, assumptions and other factors that could cause actual results or events to differ materially from those expressed or implied by the forward–looking statements. These risks, uncertainties, assumptions and factors could adversely affect the outcome and financial effects of the plans and events described herein. Additionally, these risks and uncertainties include, but are not limited to, the risks and uncertainties set forth in the “Risk Factors” section of the Company’s Annual Report on Form 20–F for the year ended December 31, 2023, filed with the Securities and Exchange Commission (“SEC”) on March 20, 2024, and subsequent reports that the Company files with the SEC. A multitude of factors including, but not limited to, changes in demand, competition and technology, can cause actual events, performance or results to differ significantly from any anticipated development. Forward looking statements contained in this press release regarding past trends or activities are not guarantees of future performance and should not be taken as a representation that such trends or activities will continue in the future. In addition, even if actual results or developments are consistent with the forward–looking statements contained in this press release, those results or developments may not be indicative of results or developments in future periods. No representations and warranties are made as to the accuracy or fairness of such forward–looking statements. As a result, the Company expressly disclaims any obligation or undertaking to release any updates or revisions to any forward–looking statements in this press release as a result of any change in expectations or any change in events, conditions, assumptions or circumstances on which these forward–looking statements are based, except if specifically required to do so by law or regulation. Neither the Company nor its advisers or representatives nor any of its subsidiary undertakings or any such person's officers or employees guarantees that the assumptions underlying such forward–looking statements are free from errors nor does either accept any responsibility for the future accuracy of the forward–looking statements contained in this press release or the actual occurrence of the forecasted developments. You should not place undue reliance on forward–looking statements, which speak only as of the date of this press release.

Contact:

Nyxoah
David DeMartino, Chief Strategy Officer
IR@nyxoah.com

For Media
Belgium/France
Backstage Communication – Gunther De Backer
gunther@backstagecom.be

International/Germany
MC Services – Anne Hennecke
anne.hennecke@mc–services.eu

Attachment


GLOBENEWSWIRE (Distribution ID 1000971439)

Warming Asian Glaciers: Regional Strategy for Riskscape

Tilicho Lake in the Himalayas is the water retention area from glaciers of the Third Pole. Credit: Unsplash/Alexis Rodriguez

By Sanjay Srivastava, Soomi Hong and Shashwat Avi
BANGKOK, Thailand, Jul 15 2024 – Scientific assessments reveal that the Third Pole (TP), encompassing the vast glaciated mountain systems of Asia, is warming at an alarming rate of over 0.3 ºC per decade, surpassing the global average.

The TP hosts the largest ice mass outside the polar region, spanning the Tibetan plateau and surrounding ranges: Pamir-Hindu Kush, Hengduan, Tienshan, Qilian, and the Himalayas. Rapid changes in the cryosphere and melting of glaciers significantly impact high-mountain ecosystems and downstream regions.

As the water tower of Asia, the TP is vital for socio-economic stability through its freshwater resources. Warming has caused considerable variations in lakes, inland water bodies and the runoff into the river basins. Additionally, glacial disasters such as ice collapse and glacial lake outburst floods (GLOFs) have become more frequent and dangerous in recent years.

Emerging Third Pole risk hotspots

While the risks emanating from warming are quite diverse in the different geographies of the TP, glacier melting has been intensifying, with more intensive melting along the Himalayas resulting in emergence of multi-hazard risk hotspots.

Recent research reveals that the Hindu Kush Himalayan (HKH) glaciers disappeared 65 per cent faster in 2011–2020 compared with the previous decade.

Future scenarios project that glaciers in the HKH could lose up to 80 per cent of their current volume by the end of the century, with snow cover projected to fall by up to a quarter under high emissions scenarios.

This may drastically reduce freshwater for major Asian rivers including the Yangtze, Indus, Ganges, Amu Darya and Helmand. The decreasing extent of frozen ground (permafrost) will lead to more landslides and problems for infrastructure at high elevation.

The changes observed in Asian high mountain cryosphere to date signal grave consequences for human life and nature. A recent example is a cloudburst over Lhonak Lake in North Sikkim, which triggered a devastating GLOF in the Teesta river basin.

This event resulted in loss of life, the destruction of the 1,200 MW Urja Hydroelectric Chungthang dam and extensive downstream damage, illustrating how disaster risks can compound and cascade in the fragile mountainous context of the Himalayas.

GLOFs pose a threat to mountainous communities across Bhutan, India, Nepal, and Pakistan; from the Himalayas to the Caucasus, Pamir, Hindu Kush-Karakoram and Tien Shan Mountain ranges.

While manifestations of warming Asian glaciers are already visible, they are going to have devastating consequences for water and food security, energy sources, ecosystems, and the lives and livelihoods of hundreds of millions across Asia, many of which will be beyond the limits of adaptation.

Science led TP regional co-operation mechanisms for weather and climate services

Given the transboundary nature of climate threats confronting the Asian glaciers, a stronger regional collaboration and knowledge exchange is required to understand the changing riskscape and develop risk reduction capabilities of the countries in diverse geographies of the TP.

The WMO’s Regional Climate Outlook Forums and Regional Climate Centres anchor unique regional and subregional co-operation architecture. Following this modality, the National Meteorological and Hydrological Services of the TP region have establish the Third Pole Regional Climate Centre Network (TPRCC-Network) to facilitate collaboration.

To capture the specificities of riskscape across TP geographies, the TPRCC-Network comprises three geographical nodes, with thematic responsibilities for mandatory functions for the entire region. While China leads the northern and eastern nodes, India and Pakistan are leading southern and western nodes of the TP. The Beijing Climate Centre provides overall co-ordination. ESCAP along with ICIMOD, TPE, GCW, GEWEX and MRI are contributing partners of the TPRCC-Network.

In early June, the TPRCC-Network issued its first ever seasonal outlook for the summer season June to September 2024 for a high mountain TP region. It highlights that surface air temperatures are likely to be above normal over most parts of the TP region, especially over the Karakoram.

The southwestern and northwestern parts are likely to experience normal to above normal surface air temperatures. Precipitation is likely to be near or above the climatological normal over most parts of the TP region, however, it is likely to be below normal in the western and southeastern parts of the TP region.

Impact forecasting with teleconnection approach in the TP

Weather forecasting relies on the interconnectedness of atmospheric and ocean conditions all the way across the globe, enabling predictions weeks to months in advance. Teleconnections denote significant links between weather phenomena across distant locations, often involving climate patterns spanning thousands of miles.

The TP is characterized by hazards of glaciers with their potential exposure, vulnerability and impacts zones which are thousands of kilometers aways across the different nodes. The impact assessment needs to be based on understanding the teleconnections of glaciers and their potential impact zones.

With the understanding of these unique teleconnections in the TP, ESCAP is making efforts to translate the seasonal outlook in terms of impact scenarios highlighting potentially at-risk communities, sectors and systems of the TP region. ESCAP has developed automation impact-based forecasting tool to help guide risk informed decision making and fill knowledge gaps.

Source of Diagram: ESCAP

Support to adaptation at altitude

Several initiatives aim to accelerate adaptation actions in the mountains, including the multi-country initiative such as the Adaptation at Altitude. These initiatives enhance resilience and adaptive capacity by improving and transferring knowledge through science–policy platforms, informing decision-making in national, regional and global policy processes.

Adaptation and resilience in the Third Pole context hinge on understanding glacier dynamics and their impact on water and ecosystems. The TRCC-Network is an important initiative to support adaptation at altitude.

Sanjay Srivastava is Chief, Disaster Risk Reduction Section, ESCAP; Soomi Hong is Associate Economic Affairs Officer, Disaster Risk Reduction Section, ESCAP; Shashwat Avi is Consultant, Disaster Risk Reduction Section, ESCAP.

The article was also co-authored by Naina Tanwar, Consultant, Disaster Risk Reduction Section, ESCAP and Akshaya Kumar, Intern, Disaster Risk Reduction Section, ESCAP

IPS UN Bureau

 


!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?’http’:’https’;if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+’://platform.twitter.com/widgets.js’;fjs.parentNode.insertBefore(js,fjs);}}(document, ‘script’, ‘twitter-wjs’);